Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 1/2017

01-01-2017 | Letter to the Editors

Acute pneumonitis and pericarditis related to alemtuzumab therapy in relapsing-remitting multiple sclerosis

Authors: María Rosario Blasco, Antonio Ramos, Celia García Malo, Antonio García-Merino

Published in: Journal of Neurology | Issue 1/2017

Login to get access

Excerpt

Dear Sirs, …
Literature
1.
Hartung H-P, Aktas O, Boyko AN (2015) Alemtuzumab: a new therapy for active relapsing–remitting multiple sclerosis. Mult Scler J 21(1):22–34CrossRef
2.
Thomas K, Eisele J, Rodriguez-Leal FA et al (2016) Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm 3(3):e228CrossRefPubMedPubMedCentral
3.
Wing MG, Moreau T, Greenwood J, Smith RM, Hale G et al (1996) Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells. J Clin Invest 98(12):2819–2826CrossRefPubMedPubMedCentral
4.
Breslin S (2007) Cytokine-release syndrome: overview and nursing implications. Clin J Oncol Nurs 11:37–42CrossRefPubMed
5.
Maggi E, Vultaggio A, Matucci A (2011) Acute infusion reactions induced by monoclonal antibody therapy. Expert Rev Clin Immunol 7:55–63CrossRefPubMed
6.
Ruck Tobias, Bittner Stefan, Wiendl Heinz, Meuth Sven G (2015) Alemtuzumab in Multiple Sclerosis: mechanism of action and beyond. Int J Mol Sci 16:16414–16439CrossRefPubMedPubMedCentral
7.
Moreau T, Coles A, Wing M, Isaacs J, Hale G, Waldmann H, Compston A (1996) Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 119(Pt 1):225–237CrossRefPubMed
Metadata
Title
Acute pneumonitis and pericarditis related to alemtuzumab therapy in relapsing-remitting multiple sclerosis
Authors
María Rosario Blasco
Antonio Ramos
Celia García Malo
Antonio García-Merino
Publication date
01-01-2017
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 1/2017
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-016-8306-x

Other articles of this Issue 1/2017

Journal of Neurology 1/2017 Go to the issue

Letter to the Editors

Response to: staircase climbing is not solely a visual compensation strategy to alleviate freezing of gait in Parkinson’s disease

Original Communication

Default-mode network connectivity in cognitively unimpaired drug-naïve patients with rigidity-dominant Parkinson’s disease

Original Communication

ALS and MMN mimics in patients with BSCL2 mutations: the expanding clinical spectrum of SPG17 hereditary spastic paraplegia

Original Communication

Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease

Original Communication

Magnetic resonance imaging of the proximal upper extremity musculature in boys with Duchenne muscular dystrophy

Erratum

Erratum to: Neuro-otology—some recent clinical advances